We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.
16 Feb 2023 - 18 Feb 2023

Global Point-of-Care Testing (POCT) Market to Surpass USD 55 Billion by 2030

By HospiMedica International staff writers
Posted on 19 Apr 2022
Print article
Image: Rising prevalence of chronic diseases is driving the global POCT market (Photo courtesy of Pexels)
Image: Rising prevalence of chronic diseases is driving the global POCT market (Photo courtesy of Pexels)

The global point of care testing (POCT) market was valued at USD 29.47 billion in 2020 and is expected to grow at a CAGR of 6.5% from 2021 to 2030 to reach USD 55.27 billion by 2030, driven by a rise in the prevalence of chronic diseases such as diabetes, rheumatism, and cancer and several supportive initiatives implemented by government and non-government organizations. However, stringent government regulations for the approval of POCT devices and reimbursement issues are expected to restrain the market growth. On the other hand, technological advancements in POCT devices and the advent of home-based POCT devices will present new growth opportunities in the coming years.

These are the latest findings of Allied Market Research (Dublin, Ireland), a full-service market research and business-consulting firm.

Owing to surge in the prevalence of COVID-19 infection across the world, there has been an increase in the demand for POCT kits such as COVID-19 rapid kits for the detection of coronavirus, thereby driving the growth of the POCT market during the pandemic. There were increased development activities of various testing and monitoring kits during this period. However, lockdown restrictions and supply chain disruptions posed distribution challenges and created a supply-chain gap.

Based on product, the glucose monitoring kits segment accounted for the highest share of the POCT market in 2020, contributing to more than two-fifths of the market, and is expected to maintain its leadership position until 2030. This can be attributed to a rise in the prevalence of target diseases such as diabetes. However, the infectious diseases testing kits segment is estimated to register the highest CAGR of 12.7% from 2021 to 2030, owing to a rise in the prevalence of infectious diseases such as hepatitis, influenza, COVID-19, & human immunodeficiency virus (HIV).

Based on end-user, the professional diagnostic centers segment held the highest share of the POCT market in 2020, contributing to more than half of the market, and is expected to maintain its dominance in terms of revenue throughout the forecast period. This can be attributed to access to novel diagnostic technologies, improvement in healthcare coverage, and affordability. However, the research laboratories segment is expected to register the fastest CAGR of 7.8% from 2021 to 2030 due to a surge in the prevalence of various chronic and infectious diseases globally.

Geographically, North America held the highest share of the global POCT market in terms of revenue in 2020, accounting for around two-fifths of the market, and is projected to maintain its leadership position until 2030. This can be attributed to the surge in COVID-19 cases in the US and Canada. However, Asia-Pacific is estimated to register the fastest CAGR of 7.8% during the forecast period due to the development of healthcare infrastructure and high prevalence of chronic and targeted diseases such as diabetes, cancer, and others, in the region.

Related Links:
Allied Market Research 

Gold Supplier
Newborn Hemoglobin Screening System
Ultrasound System
HERA W10 Elite
Smart nCPAP Device
Medical Furniture

Print article



view channel
Image: A novel research study moves the needle on predicting coronary artery disease (Photo courtesy of Pexels)

AI-Enabled ECG Analysis Predicts Heart Attack Risk Nearly as well as CT Scans

Increased coronary artery calcium is a marker of coronary artery disease that can lead to a heart attack. Traditionally, CT scans are used to diagnose buildup of coronary artery calcium, although CT scanners... Read more

Critical Care

view channel
Image: New spray fights infections and antibiotic resistance (Photo courtesy of Chalmers University of Technology)

Hydrogel-Based Spray Kills Antibiotic-Resistant Bacteria in Wounds and Biomedical Implants

Antibiotic resistance has been ranked among the top ten threats to global health by the World Health Organization (WHO). Antibiotic-resistant bacteria is estimated to cause almost 1.3 million deaths annually... Read more

Surgical Techniques

view channel
Image: The Inspira aspiration catheter has received CE Mark approval (Photo courtesy of Infinity Neuro)

Innovative Aspiration Catheter for Treatment of Stroke Delivers Next-Level Navigation Performance

Stroke is a disease that affects the arteries within and leading to the brain. Globally, stroke is the second-leading cause of death and the third-leading cause of death and disability combined.... Read more

Health IT

view channel
Image: Using digital data can improve health outcomes (Photo courtesy of Unsplash)

Electronic Health Records May Be Key to Improving Patient Care, Study Finds

When a patient gets transferred from a hospital to a nearby specialist or rehabilitation facility, it is often difficult for personnel at the new facility to access the patient’s electronic health records... Read more

Point of Care

view channel
Image: Steripath improves the diagnostic accuracy and timeliness of sepsis test results (Photo courtesy of Magnolia)

All-in-One Device Reduces False-Positive Diagnostic Test Results for Bloodstream Infections

Blood cultures are considered the gold standard diagnostic test for the detection of blood stream infections, such as sepsis. However, positive blood culture results can be frequently wrong, and about... Read more


view channel
Image: Researchers expect broader adoption of AI in healthcare in the near future (Photo courtesy of Pexels)

Artificial Intelligence (AI) Could Save U.S. Healthcare Industry USD 360 Billion Annually

The wider adoption of artificial intelligence (AI) in healthcare could save the U.S. up to USD 360 billion annually although its uptake in the industry is presently limited owing to the absence of trust... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.